[
    "{\"step_by_step_thinking\": \"Tedizolid is an antibiotic that is active against gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), as stated in Document [1]. It is also mentioned in Document [1] that tedizolid has a high oral bioavailability of approximately 90%, which contradicts option C. Document [5] lists the most common adverse effects of tedizolid found in clinical trials, which include nausea, headache, diarrhea, vomiting, and dizziness, but not peripheral neuropathy, contradicting option A. There is no mention in the documents of tedizolid being active against anaerobes, which makes option D unlikely.\", \"answer_choice\": \"B\"}"
]